Ocugen
$1.77
768
-$0.02-1.12% Today
Statistics
Day High
1.83
Day Low
1.75
52W High
2.73
52W Low
0.57
Volume
4,363,072
Avg. Volume
8,136,966
Mkt Cap
552.81M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
1MayExpected
Expected EPS
-0.051429
Actual EPS
N/A
Financials
-1,333.02%Profit Margin
Unprofitable8.11MRevenue
-108.11MNet Income
Analyst Ratings
$9.00Average Price Target
The highest estimate is 10.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow OCGN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap19.51B
BioNTech
BNTX
Mkt Cap22.92B
Novavax
NVAX
Mkt Cap1.25B
Pfizer
PFE
Mkt Cap161.09B
Johnson & Johnson
JNJ
Mkt Cap585.7B
Astrazeneca
AZN
Mkt Cap315.47B
Inovio Pharmaceuticals
INO
Mkt Cap78.07M
Arbutus Biopharma
ABUS
Mkt Cap875.74M
GSK
GSK
Mkt Cap113.29B
About
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Show more...
CEO
Dr. Shankar Musunuri M.B.A., Ph.D.
Employees
95
Country
US
ISIN
US67577C1053
Listings
0 Comments
Share your thoughts
FAQ
What is Ocugen stock price today?▼
The current price of OCGN is $1.77 USD — it has decreased by -1.12% in the past 24 hours. Watch Ocugen stock price performance more closely on the chart.
What is Ocugen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ocugen stocks are traded under the ticker OCGN.
Is Ocugen stock price growing?▼
OCGN stock has risen by +1.14% compared to the previous week, the month change is a +9.94% rise, over the last year Ocugen has showed a +167.37% increase.
What is Ocugen market cap?▼
Today Ocugen has the market capitalization of 552.81M
When is the next Ocugen earnings date?▼
Ocugen is going to release the next earnings report on May 01, 2026.
What were Ocugen earnings last quarter?▼
OCGN earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.06 USD resulting in a -2.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ocugen revenue for the last year?▼
Ocugen revenue for the last year amounts to 8.11M USD.
What is Ocugen net income for the last year?▼
OCGN net income for the last year is -108.11M USD.
How many employees does Ocugen have?▼
As of April 06, 2026, the company has 95 employees.
In which sector is Ocugen located?▼
Ocugen operates in the Health Care sector.
When did Ocugen complete a stock split?▼
The last stock split for Ocugen was on September 30, 2019 with a ratio of 1:60.
Where is Ocugen headquartered?▼
Ocugen is headquartered in Malvern, US.